FRETS-VWF73

Asp-Arg-Glu-A₂pr(Nma)-Ala-Pro-Asn-Leu-Val-Tyr-Met-Val-Thr-Gly-A₂pr(Dnp)-Pro-Ala-Ser-Asp-Glu-Ile-Lys-Arg-Leu-Pro-Gly-Asp-Ile-Gln-Val-Val-Pro-Ile-Gly-Val-Gly-Pro-Asn-Ala-Asn-Val-Gln-Glu-Leu-Glu-Arg-Ile-Gly-Trp-Pro-Asn-Ala-Pro-Ile-Leu-Ile-Gln-Asp-Phe-Glu-Thr-Leu-Pro-Arg-Glu-Ala-Pro-Asp-Leu-Val-Leu-Gln-Arg A₂pr(Nma): N^β-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid A₂pr(Dnp): N^β-(2,4-Dinitrophenyl)-2,3-diaminopropionic acid
: (Trifluoroacetate Form)
: (M.W. 8314.3) C₃₇₀H₅₈₃N₁₀₃O₁₁₃S
: Fluorescence-Quenching Substrate for ADAMTS-13

Package	Price(Yen)	Availability	Quantity
Vial 0.1 mg	32,000	contact us
バルク見積もり

Solubility: DMSO (0.4 mM)

K. Kokame, M. Matsumoto, Y. Fujimura, and T. Miyata, Blood, 103, 607 (2004). (VWF73 Sequence)
K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata, Br. J. Haematol., 129, 93 (2005). (FRETS-VWF73)
E. Groot, J.J.J. Hulstein, C.N. Rison, P.G. De Groot, and R. Fijnheer, J. Thromb. Haemost., 4, 698 (2006). (ADAMTS-13 Assay)